当前位置:首页 - 行情中心 - 羚锐制药(600285) - 财务分析

羚锐制药

(600285)

  

流通市值:126.19亿  总市值:126.47亿
流通股本:5.66亿   总股本:5.67亿

羚锐制药(600285)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润4.76亿元,每股收益0.84元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益310030.83万元,未分配利润186746.76万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产557222.75万元,负债247191.92万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入2,099,205,515.811,020,755,870.553,500,831,286.922,759,116,202.14
营业总成本1,580,082,239.98780,335,122.232,768,148,768.852,132,955,810.67
其他经营收益
营业利润551,471,072.75253,684,137.59810,301,684.55662,676,665.58
利润总额551,547,542.75253,668,892.56827,572,996.86665,105,059.05
净利润475,868,499.88216,733,789.1722,584,691.99573,907,880
每股收益
其他综合收益6,235,719.576,311,122.23-52,945,072.92-49,302,213.98
综合收益总额482,104,219.45223,044,911.33669,639,619.07524,605,666.02
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计2,346,584,704.862,004,404,855.72,458,038,247.112,262,062,502.1
非流动资产:
非流动资产合计3,225,642,764.743,406,490,925.222,558,804,960.622,623,500,075.95
资产总计5,572,227,469.65,410,895,780.925,016,843,207.734,885,562,578.05
流动负债:
流动负债合计2,393,949,476.051,986,108,168.891,874,335,175.061,917,993,701.6
非流动负债:
非流动负债合计77,969,701.1580,919,127.4662,215,968.6765,980,773.51
负债合计2,471,919,177.22,067,027,296.351,936,551,143.731,983,974,475.11
所有者权益(或股东权益):
归属于母公司股东权益合计3,066,393,164.323,311,522,505.913,072,526,287.292,893,837,629.18
股东权益合计3,100,308,292.43,343,868,484.573,080,292,0642,901,588,102.94
负债和股东权益合计5,572,227,469.65,410,895,780.925,016,843,207.734,885,562,578.05
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计2,069,419,931.08903,232,099.553,924,835,712.292,656,515,780.87
经营活动现金流出小计1,713,832,424.33785,616,199.433,048,971,479.162,306,466,328.62
经营活动产生的现金流量净额355,587,506.75117,615,900.12875,864,233.13350,049,452.25
投资活动产生的现金流量:
投资活动现金流入小计194,001,683.84159,012,139.42465,877,124.381,132,711,885.05
投资活动现金流出小计1,122,660,675.1944,785,928.441,131,709,447.721,750,214,149.76
投资活动产生的现金流量净额-928,658,991.26-785,773,789.02-665,832,323.34-617,502,264.71
筹资活动产生的现金流量:
筹资活动现金流入小计398,070,362.2911,340,271.8984,193,548.6419,592,190.83
筹资活动现金流出小计521,038,763.95617,588.12556,131,430.6469,975,832.3
筹资活动产生的现金流量净额-122,968,401.6610,722,683.77-471,937,881.96-450,383,641.47
汇率变动对现金及现金等价物的影响-18,920.46-12,982.27,770.61-3,101.42
现金及现金等价物净增加额-696,058,806.63-657,448,187.33-261,898,201.56-717,839,555.35
期末现金及现金等价物余额532,318,999.37570,929,618.671,228,377,806772,436,452.21
补充资料:
现金及现金等价物的净增加额-696,058,806.63--261,898,201.56-
最新报告期:2025-08-25
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
浙商证券丁健行,吴天昊1.481.671.872025-08-25
东海证券杜永宏1.461.681.902025-08-22
开源证券余汝意1.471.681.892025-08-20
长城证券刘鹏,袁紫馨1.461.681.882025-08-20
长城证券刘鹏,袁紫馨1.481.721.942025-07-09
TOP↑